Gauging the Impact of COVID-19 Across the Global IP Marketplace: Lessons Learned from the Novel Coronavirus
Senior Director | Global Intellectual Property
Fosun Pharma USA Inc.
Stacie L. Ropka
Axinn, Veltron & Harkrider LLP
- Reviewing the impact of COVID-19 on global biosimilars market trends
- Incentivizing the transition to biosimilars without political support
- Combatting slow adoption and low stakeholder confidence with value-based care
- Analyzing whether manufacturers pursue interchangeability designations for products
- Partnering with larger companies to advance therapies through Phase 3
Complete the form below to download the recording of the webinar.
How We Will Use Your Data
If you decide that you no longer wish to receive information about our events and products, you can contact us any time at [email protected]. Each of our marketing communications (whether by email, phone, facsimile, post or SMS) will also include an appropriate and easy way for you to unsubscribe.
American Conference Institute
Two Park Avenue, 20th Floor
New York, NY 10016 USA
E: [email protected]